1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Alterity Therapeutics Limited (ATHE)

  7. Alterity Therapeutics Limited (ATHE) News

ATHE

Alterity Therapeutics Limited
2.84
0.09 (3.27%)
Upgrade to Real-Time
Stock Name Stock Symbol Market Stock Type
Alterity Therapeutics Limited ATHE NASDAQ Depository Receipt
  Price Change Price Change % Stock Price Last Trade
Upgrade Icon
0.09 3.27% 2.84 03:04:17
Open Price Low Price High Price Close Price Previous Close
2.87 2.72 2.87 2.75
more quote information »

Recent News

Date Time Source Heading
16/3/202322:25GLOBEAlterity Therapeutics Enrolls First Patient in the U.S. in..
16/3/202321:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
14/3/202322:25GLOBEAlterity Therapeutics Announces Granting of New Composition..
09/3/202322:12EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
08/3/202323:25GLOBEAlterity Therapeutics Enrolls First Patient in Italy in..
28/2/202323:57EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
17/2/202322:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
17/2/202308:44GLOBEAlterity Therapeutics Receives Regulatory Authorization in..
02/2/202322:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
31/1/202323:25PRNUSAppendix 4C - Q2 FY23 Quarterly Cash Flow Report
31/1/202322:08EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
30/1/202322:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/1/202302:25PRNUSAlterity Therapeutics Launches ATH434 Phase 2 Clinical Trial..
09/1/202322:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
06/1/202323:25PRNUSAlterity Therapeutics Announces 1-for-10 Reverse ADS Split..
06/1/202322:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
04/1/202302:25PRNUSAlterity Therapeutics to Participate in the Sachs Associates..
30/12/202202:25PRNUSAlterity Therapeutics Announces Allowance of New Composition..
29/12/202222:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
15/12/202222:34EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
16/11/202222:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
14/11/202222:15EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
14/11/202222:13EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
14/11/202222:13EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
08/11/202202:25PRNUSAlterity Therapeutics Announces Presentation of Data from..
28/10/202222:25PRNUSAppendix 4C - Q1 FY23 Quarterly Cash Flow Report
26/10/202222:25PRNUSAlterity Therapeutics Announces Presentation of MRI Data..
14/10/202201:25PRNUSAlterity Therapeutics Launches ATH434 Phase 2 Clinical Trial..
26/9/202221:25PRNUSAlterity Therapeutics Announces Presentation of Wearable..
26/9/202220:55EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
23/9/202220:08EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
21/9/202220:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
20/9/202221:25PRNUSAlterity Therapeutics Receives U.S. FDA Approval for..
20/9/202220:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
01/9/202220:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
01/9/202202:25EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
27/8/202207:19EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
25/8/202221:25PRNUSAlterity Therapeutics Launches ATH434 Phase 2 Clinical Trial..
25/8/202220:17EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
24/8/202220:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
22/7/202221:25PRNUSAlterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash..
22/7/202220:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
21/7/202220:00EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
07/7/202201:00PRNUSAlterity Therapeutics Doses First Patient in ATH434 Phase 2..
06/7/202220:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
30/6/202220:37EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
27/6/202220:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
24/6/202222:35GLOBELife Sciences Investor Forum Presentations Now Available for..
24/6/202201:00PRNUSAlterity Therapeutics Announces Regulatory Authorization to..
23/6/202220:03EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
Your Recent History
NASDAQ
ATHE
Alterity T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230329 16:19:21